香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 R Arrail Group Limited 瑞爾集團有限公司 （於英屬維爾京群島註冊成立並於開曼群島存續的有限公司） （股份代號：6639） 正面盈利預告 本公告乃由瑞爾集團有限公司（「本公司」，連同其子公司及可變利益實體，統稱 「本集團」）根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2) (a)條及香港法例第571章證券及期貨條例第XIVA部項下的內幕消息條文（定義見 上市規則）作出。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東（「股東」）及潛在投資 者，基於對本集團截至2025年9月30日止六個月的未經審計合併管理賬目的初步 審閱及對董事會目前可得最新資料的評估，截至2025年9月30日止六個月，本集 團預期錄得除所得稅前利潤不少於人民幣20百萬元，而截至2024年9月30日止六 個月則錄得除所得稅前利潤約人民幣7.4百萬元。 預期利潤增加主要歸因於： 本公告 ...

格隆汇11月18日丨瑞尔集团(06639.HK)公告，董事会会议将于2025年11月28日(星期五)举行，藉以(其中 包括)考虑及批准公司及其附属公司截至2025年9月30日止6个月合并中期业绩及其发布，并考虑派发中 期股息(如有)。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 董事會會議日期 瑞爾集團有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此公佈，董事會會 議將於2025年11月28日（星期五）舉行，藉以（其中包括）考慮及批准本公司及其 附屬公司截至2025年9月30日止六個月之合併中期業績及其發佈，並考慮派發中 期股息（如有）。 香港，2025年11月18日 於本公告日期，董事會包括執行董事鄒其芳先生及章錦才先生，以及獨立非執行 董事劉笑梅女士、孫健先生及張磅先生。 Arrail Group Limited 瑞爾集團有限公司 （於英屬維爾京群島註冊成立並於開曼群島存續的有限公司） （股份代號：6639） 承董事會命 瑞爾集團有限公司 主席 鄒其芳先生 R ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06639 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,250,000,000 | USD | | 0.02 USD | | 25,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | 1,250,000,000 | USD | | 0.02 USD | | 25,000,000 | 本月底法定/註冊股本總額： USD 25,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 ...

Group 1 - The core viewpoint of the article highlights that 瑞尔集团 has excelled in quality operations, innovative breakthroughs, and social contributions, leading to its nomination as a respected enterprise for the 2024-2025 period by the Economic Observer [1] Group 2 - 瑞尔集团's performance metrics include outstanding indicators in quality operations, innovation, and social contributions [1] - The nomination is based on a preliminary evaluation by the respected enterprise committee of the Economic Observer [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 本月底法定/註冊股本總額： USD 25,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 | 截至月份: | | --- | | 2025年9月30日 | | 狀態: 新提交 | 致：香港交易及結算所有限公司 公司名稱: 瑞爾集團有限公司 呈交日期: 2025年10月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06639 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,250,000,000 | USD | | 0.02 USD | | 25,000,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | 0 | | 本月底結存 | | | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於英屬維爾京群島註冊成立並於開曼群島存續的有限公司） （股份代號：6639） 於2025年9月26日舉行的 股東週年大會的投票表決結果 於2025年9月26日舉行的瑞爾集團有限公司（「本公司」）股東週年大會（「股東週年 大會」）上，如日期為2025年7月28日的股東週年大會通告（「股東週年大會通告」） 所載，所有提呈的決議案均已按投票方式進行表決。 於股東週年大會日期，本公司已發行股份總數為562,095,450股每股面值0.02美元 的股份（不包括庫存股份（定義見香港聯合交易所有限公司證券上市規則（「上市 規則」））），即賦予持有人權利出席股東週年大會並於會上對決議案投票之股份總 數。於股東週年大會日期，本公司持有1,935,500股庫存股份（包括任何於由香港 中央結算有限公司設立及運作的中央結算及交收系統持有或存放的庫存股份）， 且本公司並無購回待註銷的股份。為免生疑問，庫存股份持有人應於股東週年 ...

Core Insights - The establishment of the dental implant center and geriatric specialty by Reer Group aims to tap into the growing potential of the elderly dental care market, addressing significant service gaps [1] - The elderly population faces multiple challenges in oral health, including a high prevalence of periodontal diseases and low awareness of dental care needs [1] - The Chinese dental service market is projected to reach 147.2 billion yuan in 2024, with a compound annual growth rate (CAGR) of 6.4% from 2024 to 2029, expected to exceed 200.4 billion yuan by 2029 [1] Summary by Sections Market Opportunity - Over 60% of elderly individuals suffer from missing teeth, with an average of 7.5 missing teeth for those aged 65-74, and only 63.2% of those needing restoration have received it [1] - The demand for dental implants in East and South China accounts for over half of the national total, indicating an uneven distribution of oral health resources [1] Strategic Initiatives - The new specialty aims to integrate resources to meet the needs of elderly patients, providing high-quality dental services [1] - The establishment of the center is seen as a practical response to policy initiatives and a commitment to serving the elderly population [1] Future Projections - By 2030, the dental implant market is expected to exceed 270 billion yuan, with a CAGR of 29%, and domestic replacement penetration exceeding 50% [1] - Digital diagnosis and treatment is anticipated to account for over 70% of the market, with lower-tier markets contributing more than 40% of incremental growth [1]

Investment Rating - The report maintains an "Outperform" rating for the biopharmaceutical industry [1] Core Viewpoints - The growth of healthcare expenses, which reached 9.06 trillion yuan in 2023, is outpacing GDP growth, indicating that commercial health insurance may provide a solution to the pressures faced by the medical insurance system [3][15] - The commercial health insurance sector is expected to grow significantly, with premiums projected to reach 97.74 billion yuan by 2024, driven by low penetration rates and the need for additional funding sources [20][24] - Policies are increasingly supportive of commercial health insurance, particularly in relation to innovative drugs, which are now being included in the commercial health insurance directory [71][76] Summary by Sections Part 1: Healthcare Financing System - The healthcare financing system in China consists of government, social, and personal contributions, with social contributions being the main driver for future growth [10][15] Part 2: Growth of Health Insurance - The commercial health insurance market is expected to fill a significant funding gap, with an estimated shortfall of over 1.7 trillion yuan by 2030 [21][22] - Medical insurance is the primary source of compensation within commercial health insurance, with a compensation rate of approximately 68.79% in 2022 [27][31] Part 3: Core Products of Medical Insurance - The report highlights the importance of medical insurance as a key focus area, noting that it directly compensates for medical expenses, unlike critical illness insurance [31][35] Part 4: Policy Support for Health Insurance Development - A series of policies since 2009 have aimed to promote the development of commercial health insurance, with specific targets for market size and coverage [71][72] Part 5: Investment Recommendations - The report suggests focusing on innovative drug companies with rich pipelines, DTP pharmacies, and companies in the TPA industry, as well as innovative medical devices and high-end medical service providers [77]

Core Insights - The World Dental Federation (FDI) World Dental Congress 2025 was held in Shanghai, attracting over 35,000 global professionals, highlighting the importance of oral health for overall well-being and international cooperation in the field [1] Industry Growth - The Chinese dental industry has experienced unprecedented growth since 2006, with the market size reaching 144.6 billion yuan by 2023, and the number of institutions increasing from 65,000 in 2016 to an estimated 120,000-150,000 by 2025, particularly in the private sector [3] - The perception of oral health among the Chinese population has improved significantly, with more individuals seeking dental care, although a large portion still remains untreated [4] Market Dynamics - The private dental sector, once considered highly profitable, is facing challenges due to centralized procurement policies that have halved prices for key services like implants and orthodontics, leading to profit pressures and a wave of closures [6] - However, the impact of centralized procurement on the company, Reer Group, has been minimal due to its diversified service offerings, maintaining a stable share in both implant and orthodontic services [6][7] Strategic Positioning - Reer Group employs a dual-brand strategy, with Reer Dental positioned as a high-end service provider less affected by price wars, while Reer Dental's other brand focuses on more accessible services, including participation in insurance schemes [7] - The company emphasizes the importance of preserving natural teeth and advocates for foundational treatments over implants, which are seen as a last resort [6] Future Outlook - The Chinese dental market is projected to reach 420 billion yuan by 2030, with a focus on technological innovation, service upgrades, and inclusive healthcare [8] - Reer Group is adapting to industry challenges through strategic adjustments, including leveraging AI technology, focusing on existing customer bases, and enhancing operational efficiency [8] - The company plans to expand its reach through partnerships rather than direct acquisitions, utilizing AI to support franchisees and improve service delivery [8]